An N-Ethyl-N-Nitrosourea (ENU)-Induced Dominant Negative Mutation in the JAK3 Kinase Protects against Cerebral Malaria

Chemokine Gene Expression during Fatal Murine Cerebral Malaria and Protection Due to CXCR3 Deficiency

(2014) J. Miu et al.   JOURNAL OF IMMUNOLOGY

Beta Interferon Suppresses the Development of Experimental Cerebral Malaria

(2011) Craig N. Morrell et al.   INFECTION AND IMMUNITY

Therapeutical targeting of nucleic acid-sensing Toll-like receptors prevents experimental cerebral malaria

(2011) Bernardo S. Franklin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Genetic variation and susceptibility to infection: the red cell and malaria

(2010) D. J. Weatherall   BRITISH JOURNAL OF HAEMATOLOGY

Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy

(2010) S. Balachandar et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Memory-like IFN-γ response by NK cells following malaria infection reveals the crucial role of T cells in NK cell activation by P. falciparum

(2010) Matthew B. B. McCall et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Accumulation of Plasmodium berghei-Infected Red Blood Cells in the Brain Is Crucial for the Development of Cerebral Malaria in Mice

(2010) F. G. Baptista et al.   INFECTION AND IMMUNITY

TheN-Ethyl-N-Nitrosourea-InducedGoldenticketMouse Mutant Reveals an Essential Function ofStingin theIn VivoInterferon Response toListeria monocytogenesand Cyclic Dinucleotides

(2010) John-Demian Sauer et al.   INFECTION AND IMMUNITY

Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria

(2010) James A. McQuillan et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Immune-Mediated Mechanisms of Parasite Tissue Sequestration during Experimental Cerebral Malaria

(2010) F. H. Amante et al.   JOURNAL OF IMMUNOLOGY

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

(2010) Debra M Meyer et al.   Journal of Inflammation-London

ENU Mutagenesis Reveals a Novel Phenotype of Reduced Limb Strength in Mice Lacking Fibrillin 2

(2010) Gaynor Miller et al.   PLoS One

ENU Mutagenesis Identifies Mice with Morbid Obesity and Severe Hyperinsulinemia Caused by a Novel Mutation in Leptin

(2010) Chen-Jee Hong et al.   PLoS One

Identification of a novel cerebral malaria susceptibility locus (Berr5) on mouse chromosome 19

(2009) J Berghout et al.   GENES AND IMMUNITY

JAK3: A two-faced player in hematological disorders

(2009) Melanie G. Cornejo et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

(2009) Peter Lackner et al.   MALARIA JOURNAL

An N-ethyl-N-nitrosourea mutagenesis recessive screen identifies two candidate regions for murine cardiomyopathy that map to chromosomes 1 and 15

(2009) Liliana Fernandez et al.   MAMMALIAN GENOME

Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease

(2009) J. BRIAN de SOUZA et al.   PARASITOLOGY

Genetic and genomic analyses of host-pathogen interactions in malaria

(2009) Silayuv E. Bongfen et al.   TRENDS IN PARASITOLOGY

An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance

(2008) E. Ricky Chan et al.   EXPERIMENTAL HEMATOLOGY

C5 deficiency and C5a or C5aR blockade protects against cerebral malaria

(2008) Samir N. Patel et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

(2008) G. S. V. Campanella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA